- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Feb 20, 16:00Prev. Close
276.25
Open Price
276.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 20, 15:55Prev. Close
275.90
Open Price
276.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
279.25 (323)
| Quarterly Results of Cadila Healthcare (in Rs. Cr.) | Dec '19 | Sep '19 | Jun '19 | Mar '19 | Dec '18 | |
| Net Sales/Income from operations | 1,765.70 | 1,567.30 | 1,268.70 | 1,595.60 | 1,608.90 | |
| Other Operating Income | 82.90 | 115.40 | 75.10 | 72.20 | 66.60 | |
| Total Income From Operations | 1,848.60 | 1,682.70 | 1,343.80 | 1,667.80 | 1,675.50 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 517.50 | 480.30 | 409.80 | 477.30 | 454.90 | |
| Purchase of Traded Goods | 69.50 | 97.30 | 92.70 | 101.50 | 94.90 | |
| Increase/Decrease in Stocks | 41.70 | -84.10 | -40.10 | -20.50 | -12.40 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 277.70 | 267.30 | 265.20 | 253.00 | 239.90 | |
| depreciat | 97.50 | 92.40 | 90.00 | 88.40 | 89.80 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 526.40 | 456.20 | 433.10 | 450.40 | 442.00 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 318.30 | 373.30 | 93.10 | 317.70 | 366.40 | |
| Other Income | 38.80 | 408.00 | 27.00 | 46.10 | 49.60 | |
| P/L Before Int., Excpt. Items & Tax | 357.10 | 781.30 | 120.10 | 363.80 | 416.00 | |
| Interest | 35.30 | 68.30 | 26.30 | 25.40 | -15.50 | |
| P/L Before Exceptional Items & Tax | 321.80 | 713.00 | 93.80 | 338.40 | 431.50 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 321.80 | 713.00 | 93.80 | 338.40 | 431.50 | |
| Tax | 40.20 | 85.10 | 15.10 | 76.30 | 68.20 | |
| P/L After Tax from Ordinary Activities | 281.60 | 627.90 | 78.70 | 262.10 | 363.30 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 281.60 | 627.90 | 78.70 | 262.10 | 363.30 | |
| Equity Share Capital | 102.40 | 102.40 | 102.40 | 102.40 | 102.40 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 2.75 | 6.13 | 0.77 | 2.56 | 3.55 | |
| Diluted EPS | 2.75 | 6.13 | 0.77 | 2.56 | 3.55 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 2.75 | 6.13 | 0.77 | 2.56 | 3.55 | |
| Diluted EPS. | 2.75 | 6.13 | 0.77 | 2.56 | 3.55 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
07.02.2020
Cadila Health Consolidated December 2019 Net Sales at Rs 3,638.10 crore, up 1.68% Y-o-Y
07.02.2020
Cadila Health Standalone December 2019 Net Sales at Rs 1,848.60 crore, up 10.33% Y-o-Y
06.02.2020
Cadila Health Standalone December 2019 Net Sales at Rs 1,848.60 crore, up 10.33% Y-o-Y
05.02.2020
Cadila Health Q3 profit falls 27% despite fall in tax cost; operating margin contracts 880bps
